Subscribe
shutterstock_796969141_hotaik_sung
Hotaik Sung / Shutterstock.com
11 July 2019AmericasSarah Morgan

Fed Circuit rejects Stanford DNA test appeal

The US Court of Appeals for the Federal Circuit yesterday, July 10, handed victory to researchers at the Chinese University of Hong Kong (CUHK) in a case involving a foetal testing patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Fed Circ. affirms Stanford genetics patent rejection
26 March 2021   The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.
Genetics
23andMe petitions Fed Circuit for en banc review
8 November 2019   DNA testing and analysis company 23andMe has asked the full US Court of Appeals for the Federal Circuit to review an earlier panel decision which held that one of its patents is invalid.
Americas
Federal Circuit vacates PTAB’s decision on foetal testing patent
28 June 2017   The US Court of Appeals for the Federal Circuit has vacated and remanded the Patent Trial and Appeal Board’s decision to invalidate a foetal testing patent.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

More on this story

Americas
Fed Circ. affirms Stanford genetics patent rejection
26 March 2021   The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.
Genetics
23andMe petitions Fed Circuit for en banc review
8 November 2019   DNA testing and analysis company 23andMe has asked the full US Court of Appeals for the Federal Circuit to review an earlier panel decision which held that one of its patents is invalid.
Americas
Federal Circuit vacates PTAB’s decision on foetal testing patent
28 June 2017   The US Court of Appeals for the Federal Circuit has vacated and remanded the Patent Trial and Appeal Board’s decision to invalidate a foetal testing patent.

More on this story

Americas
Fed Circ. affirms Stanford genetics patent rejection
26 March 2021   The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.
Genetics
23andMe petitions Fed Circuit for en banc review
8 November 2019   DNA testing and analysis company 23andMe has asked the full US Court of Appeals for the Federal Circuit to review an earlier panel decision which held that one of its patents is invalid.
Americas
Federal Circuit vacates PTAB’s decision on foetal testing patent
28 June 2017   The US Court of Appeals for the Federal Circuit has vacated and remanded the Patent Trial and Appeal Board’s decision to invalidate a foetal testing patent.

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler